# New Biomarkers in the Prediction of Chemotherapy-induced Cardiotoxicity.

> **NCT05992337** · — · UNKNOWN · sponsor: **Cardiology Prague** · enrollment: 200 (estimated)

## Conditions studied

- Cardiotoxicity
- Chemotherapy Effect
- Chemotherapy Induced Systolic Dysfunction

## Interventions

- **DIAGNOSTIC_TEST:** Blood sampling
- **DIAGNOSTIC_TEST:** Echocardiography
- **DIAGNOSTIC_TEST:** Cardio MRI
- **DIAGNOSTIC_TEST:** 24-hours monitoring of ECG
- **DIAGNOSTIC_TEST:** 24 hours monitoring of BP

## Key facts

- **NCT ID:** NCT05992337
- **Lead sponsor:** Cardiology Prague
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-01
- **Primary completion:** 2024-11
- **Final completion:** 2025-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-08-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05992337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05992337, "New Biomarkers in the Prediction of Chemotherapy-induced Cardiotoxicity.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05992337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*